Employees Retirement System of Texas’s Vir Biotechnology VIR Stock Holding History

Employees Retirement System of Texas’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-29,000	Closed	-$739K	–	674
2022 Q2	$739K	Hold	29,000	–	–	0.01%	641
2022 Q1	$746K	Hold	29,000	–	–	0.01%	676
2021 Q4	$1.21M	Sell	29,000 -60,000	-67%	-$2.35M	0.01%	610
2021 Q3	$3.87M	Buy	+89,000	New	+$3.85M	0.05%	414
2021 Q1	–	Sell	-122,000	Closed	-$3.27M	–	770
2020 Q4	$3.27M	Buy	+122,000	New	+$3.97M	0.05%	365

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Employees Retirement System of Texas's VIR Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Vir Biotechnology (VIR) in Q3 2022, closing a stake of 29,000 shares — an estimated $739K sold.

Employees Retirement System of Texas first reported a position in VIR in Q4 2020 and held it in 5 quarters. The position peaked at $3.87M in Q3 2021. 220 funds tracked by Wall St. Rank hold VIR as of Q3 2022.

Employees Retirement System of Texas reported no remaining Vir Biotechnology position as of Q3 2022 after selling out during the quarter.
Employees Retirement System of Texas sold 29,000 Vir Biotechnology shares in Q3 2022, an estimated $739K.
Employees Retirement System of Texas first reported a position in Vir Biotechnology in Q4 2020 and held it in 5 quarters.
Employees Retirement System of Texas's Vir Biotechnology position peaked at $3.87M in Q3 2021.
220 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.